BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shalaby WS, Ahmed OM, Waisbourd M, Katz LJ. A Review of Potential Novel Glaucoma Therapeutic Options Independent of Intraocular Pressure. Surv Ophthalmol 2021:S0039-6257(21)00223-X. [PMID: 34890600 DOI: 10.1016/j.survophthal.2021.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cvenkel B, Kolko M. Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review. J Clin Med 2022;12. [PMID: 36614952 DOI: 10.3390/jcm12010151] [Reference Citation Analysis]
2 Awad K, Awad R, Elkazaz H, Saleh M, Mehanna A. Applying the Health Belief Model to predict preference for surgical intervention versus medical therapy among patients with open-angle glaucoma. BMJ Open Ophth 2022;7:e001113. [DOI: 10.1136/bmjophth-2022-001113] [Reference Citation Analysis]
3 del Amo EM. Topical ophthalmic administration: Can a drug instilled onto the ocular surface exert an effect at the back of the eye? Front Drug Deliv 2022;2. [DOI: 10.3389/fddev.2022.954771] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lambuk L, Mohd Lazaldin MA, Ahmad S, Iezhitsa I, Agarwal R, Uskoković V, Mohamud R. Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Front Pharmacol 2022;13:875662. [DOI: 10.3389/fphar.2022.875662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Murtagh P, O’brien C. Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a “Hyst-Oric” Change in Clinical Practice? JCM 2022;11:2895. [DOI: 10.3390/jcm11102895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hirooka K, Kiuchi Y. The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma. Antioxidants 2022;11:610. [DOI: 10.3390/antiox11040610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Löscher M, Seiz C, Hurst J, Schnichels S. Topical Drug Delivery to the Posterior Segment of the Eye. Pharmaceutics 2022;14:134. [PMID: 35057030 DOI: 10.3390/pharmaceutics14010134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]